WORKING WITH

Professor David Nutt, a neuropsychopharmacology professor at Imperial College London and Chair of Drug Science, the UK’s leading independent drug research body, has published over 400 papers, 8 government reports, and 27 books. He advocates for evidence-based drug policy and researches psilocybin, MDMA, LSD, and DMT for therapeutic use.

Head of Operations at Drug Science and a legal and regulatory consultant with experience in the UK, Canada, Australia, USA, Israel, and various EU member states, James has contributed to the development of the world’s largest psychedelic Real World Evidence project, which utilizes medical psilocybin products. He is well-equipped to advise on legal and regulatory pathways.

Professor Jo Neill is a professor of Psychopharmacology at the University of Manchester. She has been conducting research in psychopharmacology for almost 30 years, specifically in the area of development of preclinical models of psychiatric disorders.

Dr. Valerie Bonnelle, a Scientific Assistant and Researcher at the Beckley Foundation, focuses on bridging the gap between ancient wisdom and modern medicine through psychedelic research. She is currently exploring interoception, embodied cognition, and heart-brain communication, specifically studying how the autonomic nervous system influences present-moment experiences and self-transcendence.

As member of Imperial College London's Centre for Psychedelic Research and Neuropsychopharmacology, focuses on reward system dysfunction and developing treatments for substance use and behavioral addictions. He leads a study on psychedelic therapy for gambling disorder and provides consulting in psychiatry clinical trials, medical psychedelics, and cannabis.

Dr. Anne Schlag, a Chartered Psychologist and Acting CEO at Drug Science, leads research for the Medical Psychedelics Working Group. With a PhD from LSE, she specializes in science, policy-making, and risk management. Her research focuses on the social, ethical, and policy dimensions of drug regulation, particularly around psychedelics, medical cannabis, patient access, and education.

Dr. Eddie Jacobs, from the University of Oxford's Department of Psychiatry and the Wellcome Centre for Ethics and Humanities, explores the clinical, ethical, and policy aspects of psychedelic-assisted psychotherapy. His DPhil project focuses on the bioethical dimensions of this therapy, aiming to map ethical challenges and propose ways to address them while minimizing risks.

She is a Research Assistant at Imperial College London's Centre for Psychedelic Research, also serves as a Clinical Trials Administrator at Cybin Inc., a company developing psychedelic-based mental health treatments. Her research focuses on uncovering the neurobiological mechanisms behind the long-term effects of psychedelics to develop new mental health therapies.

Natalia Rebollo is a Mexican lawyer specializing in International Law and Human Rights. She also studied traditional medicine and shamanism with various communities in Mexico for two years. She holds a Master's degree in Human Rights and Humanitarian Action from Sciences Po Paris. She is currently the coordinator of the Ayahuasca Defense Fund, a program of the ICEERS Foundation.

Kathryn Forcer is a Core Psychiatry Trainee (CT2) at East London NHS Foundation Trust with a focus on psychedelic-assisted therapy in mental health care. She is also an Honorary Clinical Research Fellow at The Centre for Psychedelic Research, Imperial College London, working on psychedelic clinical trials. Kathryn holds a diploma in psychedelic-assisted therapy from the Institute of Psychedelic Therapy and recently co-authored a report advocating for compassionate access to psilocybin in the UK.

Adam Waugh is a Training Coordinator at The Loop, a non-profit focused on harm reduction and well-being through drug checking. He manages event-based welfare and harm reduction services and holds an MSc in Criminology and Criminal Justice, with a dissertation on harm reduction at UK music festivals. Adam also collaborates with PsyCare UK, a charity providing similar services at festivals.